All News
Filter News
Found 808,979 articles
-
Pfizer Inc. Release: Canadian Federal Court Upholds Lipitor Patent, Decision Will Prevent Launch Of Generic Product Until 2010
12/8/2006
-
GH3 International, Inc. Announces A Licensing Agreement With Las Vegas Clinic For GH-3 Anti Aging Therapy
12/8/2006
-
Fraunhofer Center Receives $2.7 Million Grant From Bill & Melinda Gates Foundation To Develop Vaccine Technology
12/8/2006
-
Renhuang Pharmaceuticals Inc. Announces New Ginseng Product
12/8/2006
-
Integrated BioPharma, Inc. Announces Another Application Of Its AIPwLV(TM) Technology Platform
12/8/2006
-
Nano Interface Technology, Inc. Expands Application Of Its Platform Technology To Solve The Problem Of The Drug-Coated Stents
12/8/2006
-
EndoGastric Solutions, Inc. Announces 80% Success Rate Of Their Endoluminal Fundoplication (ELF) Procedure Using The EsophyX(TM) Device For The Treatment Of GERD
12/8/2006
-
Cordis Corporation Announces Clinical And Educational Programs For The CYPHER(R) Sirolimus-Eluting Coronary Stent
12/8/2006
-
VeriChip's Manufacturing Operations Quality System Re-Certified To ISO 9001:2000 Standard
12/8/2006
-
Court Sets Trial Date In Diomed Holdings, Inc. EVLT Patent Litigation
12/8/2006
-
DUSA Pharmaceuticals Clarifies USPTO Action And River's Edge Pharmaceuticals' Edge Motion
12/8/2006
-
CombiMatrix To Receive $10 Million From Acacia Research Corp. Registered Direct Offering
12/8/2006
-
Questcor Pharmaceuticals, Inc. (Headquarters) Announces Registered Direct Common Stock Offering Of $13.9 Million
12/8/2006
-
Aceto Corporation Declares Semi-Annual Cash Dividend
12/8/2006
-
Arena Pharmaceuticals, Inc. Announces Pricing Of Public Offering Of Common Stock
12/8/2006
-
Abbott Laboratories Declares 332nd Consecutive Quarterly Dividend
12/8/2006
-
Advanced Magnetics, Inc. Announces Pricing Of Public Offering Of Common Stock
12/8/2006
-
Aceto Corporation Declares Semi-Annual Cash Dividend
12/8/2006
-
MFIC Corporation Engages Kawski Investor Relations To Assist In Investor Relations And Financial Outreach
12/8/2006
-
GTx, Inc. Announces Conference Call And Webcast To Discuss Ostarine Phase II Clinical Trial Results And An Update On GTx SARM Program
12/8/2006